Skip to menu Skip to content Skip to footer

2024

Conference Publication

Cohort Profile: Improving Outcomes Of Mental Health (IOMH) A Longitudinal Clinical Study Of Families With Children With Neurodevelopmental Problems

Galligan, Dana, Payne, Leanne, Sullivan, Daniel, Bhadravathi Lokeshappa, Madhura, Ziser, Laura, Nunn, Lorelle, Wallace, Leanne, Sanders, Matthew, Cobham, Vanessa, Wray, Naomi, Henders, Anjali, Byrne, Enda, Heussler, Helen and Middeldorp, Christel M. (2024). Cohort Profile: Improving Outcomes Of Mental Health (IOMH) A Longitudinal Clinical Study Of Families With Children With Neurodevelopmental Problems. World Congress of Psychiatric Genetics WCPG 2024, Singapore, 15-19 October 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.euroneuro.2024.08.469

Cohort Profile: Improving Outcomes Of Mental Health (IOMH) A Longitudinal Clinical Study Of Families With Children With Neurodevelopmental Problems

2022

Conference Publication

AN OPEN-LABEL, TOLERABILITY AND EFFICACY STUDY OF ZYN002 (CANNABIDIOL) Administered As A Transdermal Gel To Children And Adolescents With 22Q11.2 Deletion Syndrome (INSPIRE)

Heussler, H., Cohen, J., Buchanan, C., O'Neill, C., Sebree, T. and O'Quinn, S. (2022). AN OPEN-LABEL, TOLERABILITY AND EFFICACY STUDY OF ZYN002 (CANNABIDIOL) Administered As A Transdermal Gel To Children And Adolescents With 22Q11.2 Deletion Syndrome (INSPIRE). HOBOKEN: WILEY.

AN OPEN-LABEL, TOLERABILITY AND EFFICACY STUDY OF ZYN002 (CANNABIDIOL) Administered As A Transdermal Gel To Children And Adolescents With 22Q11.2 Deletion Syndrome (INSPIRE)

2021

Conference Publication

LONGER-TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2-CL-030])

Palumbo, Joseph, Heussler, Helen, Duhig, Michael, Hurst, Terry, O'Neill, Carol and Sebree, Terri (2021). LONGER-TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2-CL-030]). 68th Annual Meeting of the American-Academy-of-Child-and-Adolescent-Psychiatry (AACAP), Electr Network, Oct 18-30, 2021. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jaac.2021.09.419

LONGER-TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2-CL-030])

2021

Conference Publication

N-of-1 Trials of Melatonin For Insomnia In Stimulant-Treated Children With ADHD (Poster and Abstract)

Ong, J., Nikles, J., Senior, H., Mitchell, G., Heussler, H. and McGree, J. (2021). N-of-1 Trials of Melatonin For Insomnia In Stimulant-Treated Children With ADHD (Poster and Abstract). UQ Medical Student research conference & showcase, Brisbane, QLD Australia, October 2021.

N-of-1 Trials of Melatonin For Insomnia In Stimulant-Treated Children With ADHD (Poster and Abstract)

2021

Conference Publication

A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome [CONNECT-FX (ZYN2-CL-016)]

Berry-Kravis, Elizabeth, Hagerman, Randi, Budimirovic, Dejan, Erickson, Craig, Heussler, Helen, Tartaglia, Nicole, Cohen, Jonathan, Dobbins, Thomas, Merikle, Elizabeth, Sebree, Terri, Tich, Nancy and Palumbo, Joseph (2021). A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome [CONNECT-FX (ZYN2-CL-016)]. NEW YORK: ELSEVIER SCIENCE INC.

A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome [CONNECT-FX (ZYN2-CL-016)]

2020

Conference Publication

ENACT: an RCT of a novel very early support program for infants at increased likelihood of autism

Whittingham, K., McGlade, A., Kulasinghe, K., Mitchell, A.E., Heussler, H. and Boyd, R.N. (2020). ENACT: an RCT of a novel very early support program for infants at increased likelihood of autism. Australasian Society for Autism Research Conference, Wellington, New Zealand, 10-11 December 2020.

ENACT: an RCT of a novel very early support program for infants at increased likelihood of autism

2020

Conference Publication

Comparison of parental expectations and clinical cut-off for improvement in sleep onset latency in children with ADHD on stimulants

Heussler, H., Ong, J., Price, A., McGree, J., Mitchell, G., Senior, H. and Nikles, J. (2020). Comparison of parental expectations and clinical cut-off for improvement in sleep onset latency in children with ADHD on stimulants. Herston Health Precinct Symposium, Brisbane, QLD Australia, December 2020.

Comparison of parental expectations and clinical cut-off for improvement in sleep onset latency in children with ADHD on stimulants

2020

Conference Publication

Melatonin for insomnia in children with attention deficit hyperactivity disorder (ADHD) on stimulants

Nikles, J., Mitchell, G., Heussler, H., Price, A., McGree, J. and Ong, J. (2020). Melatonin for insomnia in children with attention deficit hyperactivity disorder (ADHD) on stimulants. Herston Health Precinct Symposium, Brisbane, QLD Australia, December 2020.

Melatonin for insomnia in children with attention deficit hyperactivity disorder (ADHD) on stimulants

2020

Conference Publication

ENACT: an RCT of a novel very early support program for infants with an increased chance of autism

McGlade, A., Whittingham, K., Kulasinghe, K., Mitchell, A.E., Heussler, H. and Boyd, R.N. (2020). ENACT: an RCT of a novel very early support program for infants with an increased chance of autism. Children’s Health Precinct HDR Student Symposium, Brisbane, QLD Australia, 19 October 2020.

ENACT: an RCT of a novel very early support program for infants with an increased chance of autism

2020

Conference Publication

[BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY

Heussler, Helen, Duhig, Michael, Hurst, Terry, O'Neill, Carol, Gutterman, Donna and Palumbo, Joseph M. (2020). [BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY. 67th Virtual Annual Meeting of the American-Academy-of-Child-and-Adolescent-Psychiatry (AACAP), Electr Network, Oct 12-24, 2020. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jaac.2020.08.463

[BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY

2020

Conference Publication

N-Of-1 trials of melatonin for insomnia in stimulant-treated children with ADHD

Ong, J., Nikles, J., Senior, H., Mitchell, G., Heussler, H. and McGree, J. (2020). N-Of-1 trials of melatonin for insomnia in stimulant-treated children with ADHD. UQ Medical Student research conference and showcase, Brisbane, QLD, Australia, October 2020.

N-Of-1 trials of melatonin for insomnia in stimulant-treated children with ADHD

2020

Conference Publication

Phase 2 BRIGHT (An open-label tolerability and efficacy study of ZYN002 administered as a transdermal gel to children and adolescents with autism spectrum disorder): Baseline Characteristics

Heussler, Helen, Duhig, Michael, Hurst, Terry, O'Neill, Carol, Agnese, Wendy and Palumbo, Joseph M. (2020). Phase 2 BRIGHT (An open-label tolerability and efficacy study of ZYN002 administered as a transdermal gel to children and adolescents with autism spectrum disorder): Baseline Characteristics. NEW YORK: SPRINGER.

Phase 2 BRIGHT (An open-label tolerability and efficacy study of ZYN002 administered as a transdermal gel to children and adolescents with autism spectrum disorder): Baseline Characteristics

2020

Conference Publication

ENACT (Environmental enrichment for infants; parenting with Acceptance and Commitment Therapy): A randomised controlled trial for infants at risk of Autism Spectrum Disorder

Whittingham, K., McGlade, A., Kulasinghe, K., Mitchell, A.E., Heussler, H.S., Hudry, K. and Boyd, R. (2020). ENACT (Environmental enrichment for infants; parenting with Acceptance and Commitment Therapy): A randomised controlled trial for infants at risk of Autism Spectrum Disorder. 10th Biennial Australian Academy of Cerebral Palsy and Developmental Medicine Conference, Perth, WA Australia, 10-14 March 2020.

ENACT (Environmental enrichment for infants; parenting with Acceptance and Commitment Therapy): A randomised controlled trial for infants at risk of Autism Spectrum Disorder

2019

Conference Publication

Behavioural problems, functional ability and cognitive function in children with Down syndrome and sleep problems

Chawla, J., Burgess, S. and Heussler, H. (2019). Behavioural problems, functional ability and cognitive function in children with Down syndrome and sleep problems. 15th World Sleep Congress, Vancouver, BC, Canada, 20 - 25 September 2019. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.sleep.2019.11.176

Behavioural problems, functional ability and cognitive function in children with Down syndrome and sleep problems

2019

Conference Publication

Autism Edu-ECHO - supporting educators, students and families

Booth, Vicky, Moss, Perrin, Heussler, Honey and Newcomb, Dana (2019). Autism Edu-ECHO - supporting educators, students and families. 2nd Asia Pacific Conference on Integrated Care, Melbourne, VIC Australia, 11-13 November 2019. London, United Kingdom: Ubiquity Press. doi: 10.5334/ijic.s4013

Autism Edu-ECHO - supporting educators, students and families

2019

Conference Publication

QUALITATIVE STUDY TO ESTABLISH THE CONTENT VALIDITY OF THE ABC-C<sub>FXS</sub> FOR EVALUATION OF TREATMENT EFFICACY IN FRAGILE X SYNDROME

Merikle, E., Patel, , Sebree, T. B., Kreusser, C. and Heussler, H. (2019). QUALITATIVE STUDY TO ESTABLISH THE CONTENT VALIDITY OF THE ABC-CFXS FOR EVALUATION OF TREATMENT EFFICACY IN FRAGILE X SYNDROME. NEW YORK: ELSEVIER SCIENCE INC.

QUALITATIVE STUDY TO ESTABLISH THE CONTENT VALIDITY OF THE ABC-C<sub>FXS</sub> FOR EVALUATION OF TREATMENT EFFICACY IN FRAGILE X SYNDROME

2019

Conference Publication

Interim findings of the n-of-1 trials of melatonin for Insomnia in stimulant-treated children with ADHD

Ong, J., Nikles, J., Senior, H., Mitchell, G., Heussler, H. and McGree, J. (2019). Interim findings of the n-of-1 trials of melatonin for Insomnia in stimulant-treated children with ADHD. UQ Medical Student research conference and showcase, Brisbane, QLD Australia, October 2019.

Interim findings of the n-of-1 trials of melatonin for Insomnia in stimulant-treated children with ADHD

2019

Conference Publication

THE IMPACT OF SEIZURE AND GASTROESOPHAGEAL REFLUX HISTORY ON SLEEP AND BEHAVIOUR IN ANGELMAN SYNDROME

Tones, M., Cross, M., Simons, C., Napier, K., Hunter, A., Render, L., Bellgard, M. and Heussler, H. (2019). THE IMPACT OF SEIZURE AND GASTROESOPHAGEAL REFLUX HISTORY ON SLEEP AND BEHAVIOUR IN ANGELMAN SYNDROME. HOBOKEN: WILEY.

THE IMPACT OF SEIZURE AND GASTROESOPHAGEAL REFLUX HISTORY ON SLEEP AND BEHAVIOUR IN ANGELMAN SYNDROME

2019

Conference Publication

Whole-exome sequencing of patients with Angelman-like phenotypes and no aberration detected in the UBE3A gene

Williams, M., Harraway, J., McGaughran, J., Patel, C., Mehta, S., Harris, A., Lipke, M., Pinner, J., Goel, H., Hanna, B., Stutterd, C., Tan, T. Y., White, S., Yeung, A. and Heussler, H. (2019). Whole-exome sequencing of patients with Angelman-like phenotypes and no aberration detected in the UBE3A gene. 51st Conference of the European Society of Human Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), Milan, Italy, 16-19 June 2018. London, United Kingdom: Nature Publishing Group.

Whole-exome sequencing of patients with Angelman-like phenotypes and no aberration detected in the UBE3A gene

2019

Conference Publication

Many naps, one nap, none: tracking the developmental significance of sleep transition in early childhood

Thorpe, K., Smith, S., Mamun, A., Staton, S., Beatton, T., Heussler, H., LeBourgeois, M., Blair, P., Coles, L., Oaks, C. and Sinclair, G. (2019). Many naps, one nap, none: tracking the developmental significance of sleep transition in early childhood. 15th World Sleep Congress, Vancouver, Canada, 20-25 September 2019. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.sleep.2019.11.1071

Many naps, one nap, none: tracking the developmental significance of sleep transition in early childhood